CAMK2G and Glucose intolerance: After chronic corticosterone treatment, CaMKII-CB1-RS and WT mice showed largely those alterations related to human metabolic syndrome, including weight gain, visceral fat accumulation and increased food intake, except to glucose intolerance that was exclusively observed in WT mice (Figure 3A–E, Supplementary Fig. 3).